For the last reported quarter, it was expected that Humana would post earnings of $3.48 per share when it actually produced earnings of $4.16, delivering a surprise of +19.54%.

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

Humana (HUM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2022. This widely-known consensus outlook gives a ...

In 2025, Humana expects adjusted earnings per share of $16.25 ... also said it expects individual Medicare Advantage members to decline roughly 10% from 2024. Last year, the Centers for Medicare ...

Humana executives spent much of a Wednesday morning call regarding its first-quarter earnings trying to convince ... Still, Humana expects its net membership to decline next year after it finishes ...

Humana (HUM) came out with quarterly earnings of $6.88 per share ... 19.5% since the beginning of the year versus the S&P 500's decline of -19.1%. What's Next for Humana? While Humana has ...

Humana posted Q4 adjusted EPS loss of $2.16 ... with individual Medicare Advantage membership projected to decline by 550K, or 10%. Discover how Matt Maley trades sharp reversals—live this ...

Earnings per share (“EPS”) came to ... Advantage plans rated 4-star or higher will significantly decline in 2025. Humana has filed a lawsuit seeking to set aside and vacate the 2025 Star ...

Earnings were offset somewhat by an ongoing decline in Medicare Advantage membership after Humana culled underperforming plans to resuscitate margins this year. However, it’s still early in 2025 ...